Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti.
Pierre, Samuel; Bocharova, Iryna; Nguyen, Catherine; Homeus, Fabienne; Julmiste, Gaetane; Macius, Youry; Rouzier, Vanessa; Severe, Patrice; Marcelle Deschamps, Marie; Moise, Colette Guiteau; Bellot, Clovy; Wu, Johnny; Rivera, Vanessa R; Sun, Rochelle; Pape, Jean W; Liautaud, Bernard; Koenig, Serena P.
Open Forum Infect Dis ; 8(12): ofab559, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34901303

RESUMO

We compared viral suppression rates between patients who continued tenofovir disoproxil fumarate (TDF)/lamivudine (3TC) vs switched to zidovudine (ZDV)/3TC in combination with a boosted protease inhibitor after failure of first-line efavirenz/TDF/3TC. We found higher rates of viral suppression with continued TDF/3TC compared with switching to ZDV/3TC.

ENVIAR RESULTADO:
Email
Exportar
Imprimir
RSS
XML
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA